Navigation Links
CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation
Date:5/21/2008

d 2% (Grade 4). Historically, the incidence of severe OM in head and neck cancer patients receiving radiation typically ranges from 34% - 56%, depending upon the specific type of treatment.

Relief of Painful Oral Mucositis

Oncologists at 26 sites enrolled 217 patients into this open-label, non-randomized observational study, called the CAPHOSOL Oral Mucositis Follow-up Observational Registry Trial (COMFORT). Patients must have been undergoing chemotherapy and radiation and at high risk of developing OM. Thirty-one percent of the patients had head and neck cancer (HNC), 31 percent had breast cancer, 13 percent had colon cancer, eight percent had lung cancer, six percent had lymphoma and 11 percent had other tumor types. All patients in this study received CAPHOSOL, administered as an oral rinse, four to 10 times daily for an average of six to eight weeks beginning the first day of treatment. Data were reported for 171 of these patients who had completed follow-up at the time the data were analyzed for this interim report.

The study showed that 95 percent of the patients reported favorable OM scores as measured by the percentages of patients indicating Grade 0 (no adverse effects or within normal limits), Grade 1 (mild) or Grade 2 (moderate) symptom severity.

The National Cancer Institute (NCI) clinical rating for OM (oral mucositis assessed during a clinical evaluation) of Grade 0 was evident in 61 percent of patients and Grade 1 clinical OM was seen in 20 percent. An NCI functional rating of OM (reflective of how OM affects diet, swallowing, gastrointestinal function and quality of life) of Grades 0 and 1 were reported in 81 percent of patients. Sixty-five percent of patients ranked their dysphagia symptoms (difficulty swallowing) as Grade 0, while 15 percent rated their symptoms as Grade 1. Grade 0 pain was reported by 61 percent of patients and 20 percent assessed their pain as Grade 1.

Out of 112 patients undergoing chemotherapy
'/>"/>

SOURCE EUSA Pharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
2. Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies
3. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
4. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
5. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
6. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
7. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
8. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
9. Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
10. SuperGens DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine
11. Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013  Decision Resources, one of the ... pharmaceutical and healthcare issues, finds that the ... efficacy endpoints, including overall survival and time ... over surveyed U.S. and European oncologists, prescribing ... breast cancer. The two novel emerging therapies ...
(Date:5/21/2013)... MOUNTAIN VIEW, Calif. , May 21, 2013 ... the design and manufacture of wireless personal healthcare ... to broaden its reach, announcing the release of ... of wireless blood pressure monitors and scales: the ... Tracker. (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...
(Date:5/21/2013)... , May 21, 2013 BioElectronics Corp. ... consumer electronic devices, announced that CEO, ... to the FDA,s Medical Advisory Committee, Orthopedic and ... products for over the counter sales. ... its medical device classification schema," Whelan said.  "While ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... more ... study, DURANGO, Colo. and NEW HAVEN, Conn., ... innovation networks, today announced,that the company is providing ... Applied Spine,s Stabilimax NZ(R) Dynamic Spine,Stabilization System. Stabilimax ...
... 18 Worldwide markets of,approved EGFr/HEr2 inhibitors grew by ... more than $3.2 billion, exceeding total sales reported in,2005. ... for these drugs and fueling continued rapid market growth. ... 50 novel,agents targeting this pathway are in development. ...
Cached Medicine Technology:Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 2Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 3
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve ... the Creative Corridor region, is releasing results for its ... on Thursday, May 23rd at 10:30 a.m. The ... , The survey is a critical component to ... attract, nurture and retain people of diverse backgrounds, cultures ...
(Date:5/21/2013)... Modern couples have countless strains on ... Sexuality and Relationship Workshops, couples are learning the ... habits for their relationship. There are both private ... individuals at Texas Counseling. Their goal is to ... to develop long term solutions. , Developing ...
(Date:5/21/2013)... genetic features of pulmonary fibrosis by physicians and scientists ... lead to improved treatment of this deadly lung disease, ... . , The study found that a particular genetic ... fibrosis, a chronic progressive disease with a median survival ... researchers may want to consider including genetic testing in ...
(Date:5/21/2013)... of the adenoids and tonsils, is performed 500,000 times ... treatment for children with obstructive sleep apnea. However, ... executive functioning, behavior, sleep apnea symptoms, and quality of ... A study led by Susan Redline, MD, MPH, ... and Associate Clinic Director of the Division of Sleep ...
(Date:5/21/2013)... May 21, 2013 Today, Zane Benefits, ... and FSA accounts. Zane Benefits, which provides comprehensive ... is the leader in defined contribution and ... . , According to Zane Benefits’ website, the Affordable ... signed into law in 2010 and impacts many areas ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3
... LOS ANGELES, Sept. 5 In a letter sent ... on Governor,Schwarzenegger and Assembly Speaker Nunez to answer seven ... care reform, that has,not been publicly released even though ... session. The full letter available below. FTCR wrote: ...
... estrogen receptor in mammary gland development may help scientists ... to new research from the University of Cincinnati (UC). ... the National Institutes of Health (NIH) developed a standard ... the estrogen receptors role in human diseases. , Unfortunately, ...
... Sept. 5 NBTY, Inc. (NYSE: NTY ), (http://www.NBTY.com ), a leading global manufacturer and marketer of nutritional,supplements, today ... rounded):, ... ... FOR THE MONTH OF AUGUST ...
... atrial fibrillation , , WEDNESDAY, Sept. 5 (HealthDay News) -- Cardiac ... heartbeat called atrial fibrillation. , The drug, dronedarone, is not ... has proven effective in two major trials, with fewer side ... Sept. 6 issue of the New England Journal of ...
... The National Association for Sport,and Physical Education (NASPE) ... help to educate, challenge, and encourage all children ... healthy and fit life. As,the new sponsor of ... assist the nonprofit education association in promoting this,comprehensive ...
... for More Nurse Educators, WASHINGTON, Sept. 5 ... is pleased to announce that the Johnson &,Johnson ... new national,scholarship program designed to increase the number ... Minority Nurse Faculty Scholars,program will provide financial assistance ...
Cached Medicine News:Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 2Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 3Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 4Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 5Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 6Health News:New 'knock-out' gene model provides molecular clues to breast cancer 2Health News:New 'knock-out' gene model provides molecular clues to breast cancer 3Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 3Health News:Drug, Pacemaker Fight Irregular Heartbeat 2Health News:Drug, Pacemaker Fight Irregular Heartbeat 3Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 2Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 3Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 2Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 3Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: